Allow us to present KI Innovations board!

Björn O. Nilsson (Chairman), Björn Nilsson has a number of assignments within academia and research foundations. He was elected in 1996 as a member of IVA, in its department of biotechnology, and was in the years 2008–2017 the academy’s CEO. He was a board member of Universeum from 2008 to 2018. He was 2010–2018 board member of Ångpanneföreningen (ÅF), and was 2015–2018 chairman of Ångpanneföreningens Forskningsstiftelse (Åforsk), which is the largest owner of ÅF AB. Until 2005, Björn Nilsson was CEO of Karo Bio AB, in 2011–2018 he was Chairman of the Board of BioInvent International AB and in 2017–2019 he was a Board member of SweTreeTechnologies AB. He was 2015–2018 Chairman of the Board of Stockholm Science City and 2016 – July 2018 a board member of the European Institute of Innovation and Technology (EIT).

Today, Björn O. Nilsson runs the consulting company Ursus Innovation AB. Since 2017, he has been chairman of the board of the Foundation for Strategic Research (SSF), since 2017 chairman of the board of the Swedish Young Academy Foundation and since 2017 chairman of the research center CellNova at KTH.

Clara Hellner (board member), Director of Research and Innovation in the Stockholm Region. Clara Hellner is a clinical specialist and adjunct professor in child and adolescent psychiatry. She graduated from the medical program at Karolinska Institutet in Stockholm in 1987. After gaining her license to practice medicine and half-way through her specialist training to become a child- and adolescent psychiatrist, she returned to KI for PhD-training. She defended her thesis in 2001. Since then, she has been active in research and education at KI in combination with clinical tasks. In 2003, she was appointed deputy head of her department. From 2008-2011, she was appointed as Dean of Doctoral Education at Karolinska Institutet. During this period, she also chaired the International Strategy committee at KI. After completing the deanship period, she has returned to research and research management in clinical psychiatry. As Director of Centre for Psychiatry Research & Education, from 2012-17, she was responsible for promoting and supporting clinical research and education in all parts of psychiatry in Stockholm. The Centre is a joint venture between Karolinska Institutet and Stockholm County Council. Since 2018, Clara Hellner is Director of Research and Education at Stockholm Health Care Services, the second largest caregiver in Stockholm County with approximately 12000 employees.

Ingemar Petersson (board member), is a professor in orthopaedics, a rheumatologist and GP Ingemar Petersson have a research focus on musculoskeletal diseases and research in epidemiology, outcomes, work disability, patient involvement and health economics in inflammatory rheumatic disorders and musculoskeletal pain. He serves since 2013 as a visiting professor in epidemiology and health services research at Keele University, Manchester, UK which is as a basis for an extended scientific collaboration.

Ketil F. Widerberg (board member),brings around 20 years of experience from the life science and software industry. In addition to co-founded two start-up companies, Widerberg worked for many years in the Norwegian biopharmaceutical company Photocure with photodynamic technology. He also worked in the software industry for Norwegian KSD Software with logistics technology later acquired by Descartes from Canada. Since 2014 Widerberg has been Managing Director for Oslo Cancer Cluster, an oncology research and industry cluster. Widerberg holds a few biotech company board positions and was also a member of the health data expert committee from the Ministry of health in 2017. Widerberg’s educational background spans from preclinical medical school to management studies. He also holds an MBA from the University of Cambridge.

Per Samuelsson (board member), born in 1961, a partner since the year 2000 with HealthCap, a venture capital firm exclusively focused on investments in the life sciences sector. As a partner with HealthCap, Per has evaluated, invested in, and developed companies with the main objective of helping patients with unmet medical needs. The companies originate in several countries in Europe and North America, and the result has been several approved medicines. Per holds an MSc in Engineering from the Institute of Technology in Linköping, Sweden. After that, Per gained over 15 years of experience in investment banking, both in corporate finance and equity research, mainly during his time with ABB Aros Securities. Per is currently a board member of Ariceum Therapeutics GmbH, Cantando AB, Cantando Holding AB, HealthCap AB, Oncopeptides AB, Pretzel Therapeutics Inc. and Skipjack AB.

Stephanie Tigerschiöld (board member), born in 1986, obtained her medical degree from Uppsala University in 2012. She is a specialist in anesthesia and intensive care and has an especially strong interest in neurointensive care. She has worked at Karolinska University Hospital in Solna throughout her clinical career. Stephanie received a Master of Business Administration (MBA) at Hult International Business School, London, in 2022. She is also a private investor with a strong interest in medical technology. Since 2023, she is a co-founder of the professional network Square One Stockholm, which works for increased entrepreneurship and innovation in healthcare.

Rickard Sandberg (board member), born 1977, Professor of Molecular Genetics at Karolinska Institutet since 2015. Leads a research group at the Department of Cell and Molecular Biology (CMB) at Karolinska Institutet. Rickard graduated from the Biomedicine program at KI (2000) and performed his doctorate research at KI (MTC). After three years at the Massachusetts Institute of Technology (MIT) in the USA as a postdoc, Rickard received funds to start his own research group at CMB (KI) in 2008. Rickard’s group became pioneers in the development of the single-cell sequencing methodology and has made ground-breaking research discoveries, which have led to several research awards (e.g. Fernström’s young prize, Anders Jahres’ young prize, Göran Gustafsson’s prize in molecular biology) as well as meriting grants (VR Rådsprofessor, ERC starting and consolidator, Wallenberg Scholar etc.). Rickard is a member of EMBO and the Nobel Assembly at KI since 2018.